COMPUTATIONAL/INFORMATICS SHARED RESOURCE: MOLECULAR MODELING FACILITY (MMF) PROJECT SUMMARY/ABSTRACT The Molecular Modeling Facility (MMF) is available to Cancer Center members to design and interpret experiments in all areas of cancer biology through the analysis of experimental and predicted three- dimensional structures of proteins and protein complexes. Under the direction of Roland Dunbrack, PhD (MT), and the effort of a 0.35 FTE Manager, the goals of the MMF are to provide services to Cancer Center members as follows: provide consultation to facilitate a more complete understanding of the structural biology of the biomolecules that are central to their research, including ongoing support for new hypothesis-driven experimentation that leads to a deeper mechanistic understanding of cancer related cellular pathways; provide structural biology consultation in cancer genetics; provide assistance and resources for the design of anti- cancer molecular therapeutics: make available in-house designed software and web server databases that perform complex modeling of proteins and analysis of protein complexes. MMF services were provided to 15 Cancer Center members in 2014. 87% of the Cancer Center members who utilized the MMF in 2014 had peer- review funded grants. 29 Cancer Center members from all 5 Research Programs used the MMF in the period 2011-2014. The specialized services performed by the Facility are not available from commercial companies. The Facility has proven its cost-effectiveness repeatedly throughout the years of its existence with structure- based design of more effective experiments and structurally informed interpretations of their results. As far as can be determined, the MMF is the only molecular modeling facility at any NCI-designated cancer center that provides molecular modeling and consultation to investigators as a Shared Resource. Some Cancer Centers have facilities that consist only of a workstation with molecular modeling software but no staff. Models are checked visually and with model evaluation software. Methods used in the Facility have been studied and validated extensively by Dunbrack?s research laboratory, which specializes not only in software development but also in high-throughput benchmarking of methods in protein structure prediction. Institutional funds ($352,000) were used in 2015 to purchase a cluster computer for Cancer Center members. The cluster has 480 processors, and will enable the MMF to undertake comprehensive, large-scale virtual screening of compounds for investigators. The MMF is supported by a Facility Advisory Committee (FAC) that meets at least annually. Recommendations from the FAC are directed to a governing Facility Parent Oversight Committee that serves to ensure that the MMF continues to have resources necessary to provide the highest quality services for Cancer Center members. Demand for services is expected to increase in the next cycle of the CCSG due to plans to recruit in all 5 Programs and new demand from Cancer Center members at TU.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA006927-55
Application #
9996569
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
1997-07-01
Project End
2021-07-31
Budget Start
2020-08-01
Budget End
2021-07-31
Support Year
55
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Research Institute of Fox Chase Cancer Center
Department
Type
DUNS #
064367329
City
Philadelphia
State
PA
Country
United States
Zip Code
19111
Diefenbach, Michael A; Benedict, Catherine; Miller, Suzanne M et al. (2018) Examining the impact of a multimedia intervention on treatment decision-making among newly diagnosed prostate cancer patients: results from a nationwide RCT. Transl Behav Med 8:876-886
Ross, Kayleigh C; Chin, Kevin F; Kim, Daehwan et al. (2018) Methotrexate sensitizes drug-resistant metastatic melanoma cells to BRAF V600E inhibitors dabrafenib and encorafenib. Oncotarget 9:13324-13336
Shafi, Ayesha A; Schiewer, Matthew J; de Leeuw, Renée et al. (2018) Patient-derived Models Reveal Impact of the Tumor Microenvironment on Therapeutic Response. Eur Urol Oncol 1:325-337
Mazor, Anna M; Mateo, Alina M; Demora, Lyudmila et al. (2018) Breast conservation versus mastectomy in patients with T3 breast cancers (>?5 cm): an analysis of 37,268 patients from the National Cancer Database. Breast Cancer Res Treat :
Ingram, Justin P; Tursi, Sarah; Zhang, Ting et al. (2018) A Nonpyroptotic IFN-?-Triggered Cell Death Mechanism in Nonphagocytic Cells Promotes Salmonella Clearance In Vivo. J Immunol 200:3626-3634
Chang, Wen-Chi L; Jackson, Christina; Riel, Stacy et al. (2018) Differential preventive activity of sulindac and atorvastatin in Apc+/Min-FCCCmice with or without colorectal adenomas. Gut 67:1290-1298
Mishra, Om P; Popov, Anatoliy V; Pietrofesa, Ralph A et al. (2018) Synthetic secoisolariciresinol diglucoside (LGM2605) inhibits myeloperoxidase activity in inflammatory cells. Biochim Biophys Acta Gen Subj 1862:1364-1375
Mortazavi, S M J; Bevelacqua, J J; Fornalski, K W et al. (2018) Comments on ""Space: The Final Frontier-Research Relevant to Mars"". Health Phys 114:344-345
Esposito, Andrew C; Crawford, James; Sigurdson, Elin R et al. (2018) Omission of radiotherapy after breast conservation surgery in the postneoadjuvant setting. J Surg Res 221:49-57
Dong, Yanqun; Zaorsky, Nicholas G; Li, Tianyu et al. (2018) Effects of interruptions of external beam radiation therapy on outcomes in patients with prostate cancer. J Med Imaging Radiat Oncol 62:116-121

Showing the most recent 10 out of 1280 publications